期刊文献+

代谢综合征对非肌层浸润性膀胱肿瘤二次电切阳性的临床意义 被引量:2

Clinical significance of metabolic syndrome in re-TURBT of non-muscular invasive bladder cencer
下载PDF
导出
摘要 目的探讨代谢综合征(MS)对非肌层浸润性膀胱肿瘤二次电切阳性的影响因素及对术后复发的影响。方法回顾性收集北京医院泌尿外科2013年1月至2018年12月因非肌层浸润性膀胱肿瘤行二次经尿道膀胱肿瘤电切术(re-TURBT)患者的临床资料以及术后定期随访资料,共计92例,分为MS组(n=50)和非MS组(n=42),分析2组患者的re-TURBT阳性的影响因素及对术后复发的影响情况。结果MS组re-TURBT的阳性率(34.0%),术后3个月阳性患者复发率为29.4%,阴性患者无复发,总复发率为10.0%;非MS的re-TURBT的阳性率(19.0%),术后3个月阳性患者和阴性患者无复发,总复发率为0%。MS组和非MS组re-TURBT的阳性率无统计学意义,二者的阳性患者复发率和总体复发率有统计学意义(P<0.05)。Logistics回归分析体质指数(BMI)、血糖、血脂及肿瘤大小是re-TURBT阳性率的独立因素。结论非肌层浸润性膀胱癌合并MS的患者re-TURBT的阳性率不高于非MS患者,但是与re-TURBT的结果和复发相关。 Objective To investigate the effect of metabolic syndrome(MS)on the positive rate and recurrence of repeat transurethral resection of bladder tumor(re-TURBT)of non-muscular invasive bladder cancer(NMIBC).Methods Clinical and follow-up data of 92 NMIBC cases who received re-TURBT during Jan.2013 and Dec.2018 were retrospectively analyzed.The patients were divided into MS group(n=50)and non-MS group(n=42).The influencing factors of re-TURBT and recurrence were compared between the two groups.Results In the MS group,the positive rate of re-TURBT was 34.0%,3-month recurrence rate was 29.4%in the positive patients and 0 in the negative patients,and the total recurrence rate was 10.0%.In the non-MS group,the positive rate of re-TURBT was 19.0%,3-month recurrence rate was 0 in both positive and negative patients,and the total recurrence rate was 0.There was no significant difference in the positive rate of re-TURBT between MS group and non-MS group,but there was statistical significance in the recurrence rate of positive patients and overall recurrence rate(P<0.05).Logistic regression analysis showed that BMI,blood glucose,blood lipid and tumor size were independent factors of the positive rate of re-TURBT.Conclusion The positive rate of re-TURBT in NMIBC patients complicated with MS is not higher than that in NMIBC patients without MS,but MS is related to the results of re-TURBT and recurrence.
作者 付春龙 张亚群 侯惠民 刘建勇 王淼 王鑫 宋新达 吴鹏杰 陈佳 程万里 王建业 刘明 FU Chun-long;ZHANG Ya-qun;HOU Hui-min;LIU Jian-yong;WANG Miao;WANG Xin;SONG Xin-da;WU Peng-jie;CHEN Jia;CHENG Wan-li;WANG Jian-ye;LIU Ming(Department of Urology,Beijing Hospital,National Center of Gerontology,Institude of Geriatric Medicine,The Joint Unit of the Chinese Academy of Medical Sciences,Beijing 100730,China)
出处 《现代泌尿外科杂志》 CAS 2020年第8期689-692,共4页 Journal of Modern Urology
基金 中国医学科学院医学与健康科技创新工程项目(No.2018-I2M-1-002) 磁共振与超声图像融合引导前列腺靶向穿刺与经会阴随机穿刺活检的比较性研究(No.BJ-2018-090)。
关键词 非肌层浸润性膀胱肿瘤 二次电切 代谢综合征 阳性率 膀胱肿瘤 non-muscular invasive bladder cancer repeat transurethral resection of bladder tumor metabolic syndrome positive rate bladder neoplasm
  • 相关文献

参考文献6

二级参考文献39

  • 1Kurella M,Lo JC,Chertow GM.Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults [J].J Am Soc Nephrol,2005,16:2134-2140.
  • 2Martin RM,Vatten L,Gunnell D,et al.Components of the metabolic syndrome and risk of prostate cancer:the HUNT 2 cohort,Norway [J].Cancer Causes Control,2009,20:1181-1192.
  • 3Siegel AB,Zhu AX.Metabolic syndrome and hepatocellular carcinoma[J].Cancer,2009,115:5651-5661.
  • 4Stocks T,Lukanova A,Johansson M,et al.Components of the metabolic syndrome and colorectal cancer risk:a prospective study [J].Int J Obes(Lond),2008,32:304-314.
  • 5Kabat GC,Kim M,Chlebowski RT,et al.A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer [J].Cancer Epidemiol Biomarkers Prev,2009,18:2046-2053.
  • 6Selph JP,Whited WM,Smith AB,et al.Metabolic syndrome as a predictor for postoperative complications after urologic surgery [J]. Urology,2014,83;1051-1059.
  • 7De Nunzio C,Aronson W,Freedland SJ,et al.The correlation between metabolic syndrome and prostatic diseases [J].Eur Urol,2012,61:560-570.
  • 8Cantiello F,Cicione A,Salonia A,et al.Association between metabolic syndrome,obesity,diabetes mellitus and oncological outcomes of bladder cancer:a systematic review[J].Int J Urol,2015,22:22-32.
  • 9Ozbek E,Otunctemur A,Dursun M,et al.Association between the metabolic syndrome and high tumor grade and stage of primary urothelial cell carcinoma of the bladder [J].Asian Pac J Cancer Prev,2014,15:1447-1451.
  • 10Holick CN,Giovannucci EL,Stampfer MJ,et al.Prospective study of body mass index,height,physical activity and incidence of bladder cancer in US men and women [J].Int J Cancer,2007,120:140-146.

共引文献81

同被引文献14

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部